Literature DB >> 33529160

Bite of the wolf: innate immune responses propagate autoimmunity in lupus.

Sarthak Gupta, Mariana J Kaplan.   

Abstract

The etiopathogenesis of systemic lupus erythematosus (SLE), a clinically heterogeneous multisystemic syndrome that derives its name from the initial characterization of facial lesions that resemble the bite of a wolf, is considered a complex, multifactorial interplay between underlying genetic susceptibility factors and the environment. Prominent pathogenic factors include the induction of aberrant cell death pathways coupled with defective cell death clearance mechanisms that promote excessive externalization of modified cellular and nuclear debris with subsequent loss of tolerance to a wide variety of autoantigens and innate and adaptive immune dysregulation. While abnormalities in adaptive immunity are well recognized and are key to the pathogenesis of SLE, recent findings have emphasized fundamental roles of the innate immune system in the initiation and propagation of autoimmunity and the development of organ damage in this disease. This Review focuses on recent discoveries regarding the role of components of the innate immune system, specifically neutrophils and interferons, in promoting various aspects of lupus pathogenesis, with potential implications for novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33529160      PMCID: PMC7843222          DOI: 10.1172/JCI144918

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  198 in total

1.  T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses.

Authors:  Kati Tillack; Petra Breiden; Roland Martin; Mireia Sospedra
Journal:  J Immunol       Date:  2012-02-20       Impact factor: 5.422

2.  Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.

Authors:  Melissa E Munroe; Rufei Lu; Yan D Zhao; Dustin A Fife; Julie M Robertson; Joel M Guthridge; Timothy B Niewold; George C Tsokos; Michael P Keith; John B Harley; Judith A James
Journal:  Ann Rheum Dis       Date:  2016-01-25       Impact factor: 19.103

3.  Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.

Authors:  Dacheng Ding; Hemal Mehta; W Joseph McCune; Mariana J Kaplan
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

4.  Neutrophil extracellular traps downregulate lipopolysaccharide-induced activation of monocyte-derived dendritic cells.

Authors:  Lorena Barrientos; Alexandre Bignon; Claire Gueguen; Luc de Chaisemartin; Roseline Gorges; Catherine Sandré; Laurent Mascarell; Karl Balabanian; Saadia Kerdine-Römer; Marc Pallardy; Viviana Marin-Esteban; Sylvie Chollet-Martin
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

5.  Recombinant human Dnase I (rhDNase) in patients with lupus nephritis.

Authors:  J C Davis; S Manzi; C Yarboro; J Rairie; I Mcinnes; D Averthelyi; D Sinicropi; V G Hale; J Balow; H Austin; D T Boumpas; J H Klippel
Journal:  Lupus       Date:  1999       Impact factor: 2.911

6.  Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages.

Authors:  J Michelle Kahlenberg; Carmelo Carmona-Rivera; Carolyne K Smith; Mariana J Kaplan
Journal:  J Immunol       Date:  2012-12-24       Impact factor: 5.422

7.  Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.

Authors:  Emily C Somers; Wenpu Zhao; Emily E Lewis; Lu Wang; Jeffrey J Wing; Baskaran Sundaram; Ella A Kazerooni; W Joseph McCune; Mariana J Kaplan
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

8.  Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis.

Authors:  J P Seery; J M Carroll; V Cattell; F M Watt
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

Review 9.  Innate Immune Cells' Contribution to Systemic Lupus Erythematosus.

Authors:  Andrés A Herrada; Noelia Escobedo; Mirentxu Iruretagoyena; Rodrigo A Valenzuela; Paula I Burgos; Loreto Cuitino; Carolina Llanos
Journal:  Front Immunol       Date:  2019-04-15       Impact factor: 7.561

10.  Monosodium urate crystals induce extracellular DNA traps in neutrophils, eosinophils, and basophils but not in mononuclear cells.

Authors:  Christine Schorn; Christina Janko; Melanie Latzko; Ricardo Chaurio; Georg Schett; Martin Herrmann
Journal:  Front Immunol       Date:  2012-09-03       Impact factor: 7.561

View more
  11 in total

Review 1.  Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus.

Authors:  Christopher B Oliveira; Mariana J Kaplan
Journal:  Semin Immunopathol       Date:  2022-03-30       Impact factor: 11.759

2.  Systemic Lupus Erythematosus and Hereditary Coproporphyria: Two Different Entities Diagnosed by WES in the Same Patient.

Authors:  Anlei Liu; Lingli Zhou; Huadong Zhu; Yi Li; Jing Yang
Journal:  Biomed Res Int       Date:  2022-05-28       Impact factor: 3.246

3.  CASP-Model Sepsis Triggers Systemic Innate Immune Responses Revealed by the Systems-Level Signaling Pathways.

Authors:  Hannan Ai; Bizhou Li; Fanmei Meng; Yuncan Ai
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

4.  The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps.

Authors:  Brendan Antiochos; Daniela Trejo-Zambrano; Paride Fenaroli; Avi Rosenberg; Alan Baer; Archit Garg; Jungsan Sohn; Jessica Li; Michelle Petri; Daniel W Goldman; Christopher Mecoli; Livia Casciola-Rosen; Antony Rosen
Journal:  Elife       Date:  2022-05-24       Impact factor: 8.713

5.  Targeting the Myddosome in Systemic Autoimmunity: Ready for Prime Time?

Authors:  Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2021-11-02       Impact factor: 15.483

Review 6.  Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach.

Authors:  Yoshiya Tanaka; Yiming Luo; John J O'Shea; Shingo Nakayamada
Journal:  Nat Rev Rheumatol       Date:  2022-01-05       Impact factor: 32.286

7.  ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies.

Authors:  Der-Yuan Chen; Yen-Hsiang Huang; Yi-Ming Chen; Jeremy J W Chen; Tsung-Ying Yang; Gee-Chen Chang; Kuo-Tung Tang
Journal:  Lupus Sci Med       Date:  2021-11

Review 8.  The Role of NLRP3 Inflammasome in Lupus Nephritis.

Authors:  Camila Barbosa Oliveira; Camilla Albertina Dantas Lima; Gisele Vajgel; Paula Sandrin-Garcia
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 9.  The Interactions Between Autoinflammation and Type 2 Immunity: From Mechanistic Studies to Epidemiologic Associations.

Authors:  McKella Sylvester; Aran Son; Daniella M Schwartz
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

Review 10.  Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases.

Authors:  Philippe Georgel
Journal:  Cells       Date:  2021-05-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.